
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
RETRACTED ARTICLE: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2
Guizhi Jia, Yan Wang, Chengjie Lin, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 60
Guizhi Jia, Yan Wang, Chengjie Lin, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 60
Showing 1-25 of 60 citing articles:
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1049-1082
Open Access | Times Cited: 87
Tongxin Ge, Xiang Gu, Renbing Jia, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1049-1082
Open Access | Times Cited: 87
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 47
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 47
The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications
Ziying Liu, Lei Gao, Long Cheng, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 487-501
Open Access | Times Cited: 39
Ziying Liu, Lei Gao, Long Cheng, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 487-501
Open Access | Times Cited: 39
Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments
Qing Tang, Siqi Wu, Baiming Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117257-117257
Open Access | Times Cited: 11
Qing Tang, Siqi Wu, Baiming Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117257-117257
Open Access | Times Cited: 11
METTL3-mediated m6A modification of lncRNA TSPAN12 promotes metastasis of hepatocellular carcinoma through SENP1-depentent deSUMOylation of EIF3I
Bei Li, Xianze Xiong, Jianrong Xu, et al.
Oncogene (2024) Vol. 43, Iss. 14, pp. 1050-1062
Open Access | Times Cited: 9
Bei Li, Xianze Xiong, Jianrong Xu, et al.
Oncogene (2024) Vol. 43, Iss. 14, pp. 1050-1062
Open Access | Times Cited: 9
N6‐methyladenosine‐modified lncRNA ARHGAP5‐AS1 stabilises CSDE1 and coordinates oncogenic RNA regulons in hepatocellular carcinoma
Jiandong Liu, Nasha Zhang, Jiajia Zeng, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 11
Open Access | Times Cited: 33
Jiandong Liu, Nasha Zhang, Jiajia Zeng, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 11
Open Access | Times Cited: 33
N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies
Xianlei Cai, Chao Liang, Miaozun Zhang, et al.
Cancer Letters (2022) Vol. 544, pp. 215815-215815
Closed Access | Times Cited: 31
Xianlei Cai, Chao Liang, Miaozun Zhang, et al.
Cancer Letters (2022) Vol. 544, pp. 215815-215815
Closed Access | Times Cited: 31
Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis
Dexin Shen, Zhao Deng, Wei Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 17
Dexin Shen, Zhao Deng, Wei Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 17
Dynamic RNA methylation modifications and their regulatory role in mammalian development and diseases
Wenlan Yang, Yongliang Zhao, Yun‐Gui Yang
Science China Life Sciences (2024)
Closed Access | Times Cited: 8
Wenlan Yang, Yongliang Zhao, Yun‐Gui Yang
Science China Life Sciences (2024)
Closed Access | Times Cited: 8
Targeting RNA N6-methyladenosine modification: a precise weapon in overcoming tumor immune escape
Wei Li, Yi Hao, Xingda Zhang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Wei Li, Yi Hao, Xingda Zhang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 28
N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway
Chengjie Lin, Yan Wang, Yihong Dong, et al.
Biology Direct (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 27
Chengjie Lin, Yan Wang, Yihong Dong, et al.
Biology Direct (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 27
Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications
Jinxin Tang, Jinhui Zhang, Lu Yu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 15
Jinxin Tang, Jinhui Zhang, Lu Yu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 15
Multifaceted roles of aerobic glycolysis and oxidative phosphorylation in hepatocellular carcinoma
Ying Zhang, Wenhuan Li, Yuan Bian, et al.
PeerJ (2023) Vol. 11, pp. e14797-e14797
Open Access | Times Cited: 14
Ying Zhang, Wenhuan Li, Yuan Bian, et al.
PeerJ (2023) Vol. 11, pp. e14797-e14797
Open Access | Times Cited: 14
Long noncoding RNA SNHG1 promotes breast cancer progression by regulating the miR-641/RRS1 axis
Lin Deng, Jun Wang, Junying Song, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Lin Deng, Jun Wang, Junying Song, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
CDKN3 Overcomes Bladder Cancer Cisplatin Resistance via LDHA-Dependent Glycolysis Reprogramming
Mengxuan Li, Nan Che, Yu Jin, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 299-311
Open Access | Times Cited: 21
Mengxuan Li, Nan Che, Yu Jin, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 299-311
Open Access | Times Cited: 21
Glycolysis-Related LINC02432/Hsa-miR-98–5p/HK2 Axis Inhibits Ferroptosis and Predicts Immune Infiltration, Tumor Mutation Burden, and Drug Sensitivity in Pancreatic Adenocarcinoma
Peng Tan, Mo Li, Zhuoran Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Peng Tan, Mo Li, Zhuoran Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer
Xi Xiong, Chen Chen, Xinxin Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Xi Xiong, Chen Chen, Xinxin Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
New horizons for the role of RNA N6-methyladenosine modification in hepatocellular carcinoma
Yujia Li, Yangling Qiu, Meng-ran Li, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 6, pp. 1130-1141
Closed Access | Times Cited: 4
Yujia Li, Yangling Qiu, Meng-ran Li, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 6, pp. 1130-1141
Closed Access | Times Cited: 4
Noncoding RNAs and RNA-binding proteins: emerging governors of liver physiology and metabolic diseases
Christian Sommerauer, Claudia Kutter
AJP Cell Physiology (2022) Vol. 323, Iss. 4, pp. C1003-C1017
Closed Access | Times Cited: 17
Christian Sommerauer, Claudia Kutter
AJP Cell Physiology (2022) Vol. 323, Iss. 4, pp. C1003-C1017
Closed Access | Times Cited: 17
FTO-mediated LINC01134 stabilization to promote chemoresistance through miR-140-3p/WNT5A/WNT pathway in PDAC
Lu Jin, Yongsheng Yang, Xiangliang Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 10
Lu Jin, Yongsheng Yang, Xiangliang Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 10
The RNA M5C methyltransferase NSUN2 promotes progression of hepatocellular carcinoma by enhancing PKM2-mediated glycolysis
Qin Qi, Rui Zhong, Yan Huang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Qin Qi, Rui Zhong, Yan Huang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
NXPH4 Promotes Gemcitabine Resistance in Bladder Cancer by Enhancing Reactive Oxygen Species and Glycolysis Activation through Modulating NDUFA4L2
Decai Wang, Pu Zhang, Zijian Liu, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3782-3782
Open Access | Times Cited: 16
Decai Wang, Pu Zhang, Zijian Liu, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3782-3782
Open Access | Times Cited: 16
RNA m6A modification in liver biology and its implication in hepatic diseases and carcinogenesis
Wenbo Ma, Tong Wu
AJP Cell Physiology (2022) Vol. 323, Iss. 4, pp. C1190-C1205
Open Access | Times Cited: 15
Wenbo Ma, Tong Wu
AJP Cell Physiology (2022) Vol. 323, Iss. 4, pp. C1190-C1205
Open Access | Times Cited: 15
Long Noncoding RNA Signatures as Cancer Biomarkers
Aina Maria Mas, Maite Huarte
Journal of Clinical Oncology (2023) Vol. 41, Iss. 16, pp. 3059-3062
Closed Access | Times Cited: 9
Aina Maria Mas, Maite Huarte
Journal of Clinical Oncology (2023) Vol. 41, Iss. 16, pp. 3059-3062
Closed Access | Times Cited: 9
TFAP2A activates HMGA1 to promote glycolysis and lung adenocarcinoma progression
Junjie Zhao, Gang Lan
Pathology - Research and Practice (2023) Vol. 249, pp. 154759-154759
Closed Access | Times Cited: 8
Junjie Zhao, Gang Lan
Pathology - Research and Practice (2023) Vol. 249, pp. 154759-154759
Closed Access | Times Cited: 8